CLEARVISTA HEALTH & WELNESS — History
CCN 364052 | 3-year financial timeline | COVID resilience: 21/100
🛡️ Public data only — no PHI permitted on this instance.
$10M
Latest Revenue (FY2022)
-9.2%
Revenue CAGR (3yr)
-13.6%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $12M | $10M | $10M | -6.2% | -9.2% |
| Operating Expenses | $9M | $10M | $11M | +14.0% | +9.2% |
| Operating Margin | 21.5% | 6.6% | -13.6% | -306.2% | +0.0% |
| Net Income | $2M | $1M | $-1M | -293.4% | +0.0% |
| Licensed Beds | 52 | 52 | 52 | +0.0% | +0.0% |
| Total Patient Days | 13,604 | 10,511 | 12,425 | +18.2% | -4.4% |
| Medicare Day % | 23% | 18% | 10% | -44.9% | -33.7% |
| Medicaid Day % | 1% | 1% | 0% | -62.6% | -35.2% |
COVID Impact & Recovery
Resilience Score: 21/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: -17.5% ($12M → $10M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▼ Declining
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
-9.2%
This Hospital
+7.6%
State Avg
Latest Margin
-13.6%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $9M | -31.1% |
| FY2024 (proj) | $8M | -48.6% |
| FY2025 (proj) | $7M | -66.1% |